The coronary stents market value will witness a considerable growth on account of growing geriatric population and rising prevalence of cardiovascular disorders along with their associated risk factors such as stroke, type II diabetes, hypertension, and chronic kidney disease, among many others. In fact, in 2017, approximately 92.1 million people across the U.S were affected by these diseases. The rising adoption of drug eluting stents and technological advancements in coronary stent technologies is also greatly contributing towards market growth.

Stents are small and expandable tubes meant for treating narrowed arteries in human body. This can be a vein or an artery or some other structure for instance the tube that carries ureter or urine. A coronary stent is a small, expandable mesh tube which is made of medical-grade cobalt alloy metal or stainless steel. It is usually placed in a coronary artery mainly after balloon angioplasty.

Use of coronary stents prevents the arteries from re-closing. Besides providing structural support to the coronary artery, some new and technologically advanced stents come with a medicated coating so as to aid in preventing the vessel from re-narrowing.

The coronary stents market is bifurcated in terms of product, end-use, and regional landscape.

With respect to product, the market for coronary stents is classified into bioresorbable vascular scaffold, bare metal drugs, and drug eluting drugs. In 2020, the drug eluting stents segment accounted for $5.7 billion and is estimated to follow robust growth trend over the coming time period. This type of stent is usually coated with time-release drug. That medicine is slowly released into the blood vessel in order to prevent it from being blocked again. Drug-eluting stents also help in preventing the reappearance of symptoms like chest pain.

In terms of application, the overall coronary stents market is segmented into ambulatory surgical centers, cardiac centers, hospitals, and others. Cardiac centers will exhibit a market revenue of more than $3.9 billion by the end of the analysis timeline.

From a regional frame of reference, in 2020, coronary stents market in Latin America accounted for around 5.6% of the market share. The region is expected to witness a strong growth trend over the coming time period.

Meanwhile, the MEA coronary stents market is anticipated to show steady growth of 3.2% during the analysis time period. Improved standards of living resulted in drastic lifestyle changes among the UAE people. This has further given rise to risk factors linked with non-communicable diseases, including cardiovascular diseases. Thus, these factors are likely to drive the demand for coronary stents across the region.